Total Payments
$102,367
2024 Payments
$604.82
Companies
46
Transactions
821
Medicare Patients
5,894
Medicare Billing
$458,733
Payment Breakdown by Category
Research$92,098 (90.0%)
Food & Beverage$10,207 (10.0%)
Education$62.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $92,098 | 3 | 90.0% |
| Food and Beverage | $10,207 | 808 | 10.0% |
| Education | $62.99 | 10 | 0.1% |
Payments by Type
Research
$92,098
3 transactions
General
$10,270
818 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $92,098 | 3 | $0 (2020) |
| Novo Nordisk Inc | $1,244 | 90 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,017 | 115 | $0 (2024) |
| PFIZER INC. | $850.33 | 107 | $0 (2024) |
| Amgen Inc. | $812.22 | 51 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $803.18 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $794.39 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $620.56 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $473.38 | 52 | $0 (2024) |
| Lilly USA, LLC | $452.35 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $604.82 | 31 | ABBVIE INC. ($112.95) |
| 2023 | $1,007 | 59 | PFIZER INC. ($140.11) |
| 2022 | $1,019 | 67 | PFIZER INC. ($139.59) |
| 2021 | $854.41 | 50 | Novo Nordisk Inc ($151.88) |
| 2020 | $4,109 | 72 | Eli Lilly and Company ($3,257) |
| 2019 | $90,501 | 146 | Eli Lilly and Company ($88,841) |
| 2018 | $2,030 | 186 | AstraZeneca Pharmaceuticals LP ($219.21) |
| 2017 | $2,243 | 210 | Novo Nordisk Inc ($250.22) |
All Payment Transactions
821 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: VACCINE | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: DIABETES | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: VACCINES | ||||||
| 05/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.47 | General |
| Category: Cardiovascular | ||||||
| 03/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.41 | General |
| Category: Cardiovascular | ||||||
| 03/15/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: VACCINE | ||||||
| 03/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 01/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK | Eli Lilly and Company | $92,098 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,371 | 4,046 | $223,714 | $128,562 |
| 2022 | 21 | 1,249 | 3,790 | $187,878 | $102,046 |
| 2021 | 27 | 1,874 | 4,578 | $217,721 | $121,816 |
| 2020 | 21 | 1,400 | 4,489 | $215,147 | $106,309 |
Total Patients
5,894
Total Services
16,903
Medicare Billing
$458,733
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 479 | $73,787 | $37,571 | 50.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,440 | $41,640 | $26,578 | 63.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 160 | 160 | $13,620 | $12,130 | 89.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 187 | $23,001 | $10,402 | 45.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 40 | $12,600 | $8,060 | 64.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $7,773 | $6,175 | 79.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 245 | 696 | $6,714 | $5,778 | 86.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 163 | 168 | $6,675 | $4,948 | 74.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 26 | $6,500 | $4,050 | 62.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 41 | 196 | $7,644 | $2,771 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $4,060 | $2,282 | 56.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 41 | $2,993 | $1,486 | 49.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 21 | 29 | $3,625 | $1,150 | 31.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 25 | $3,675 | $1,117 | 30.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 14 | 192 | $1,344 | $806.40 | 60.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 25 | $1,950 | $746.41 | 38.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 11 | $660.00 | $553.08 | 83.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 26 | 26 | $520.00 | $455.52 | 87.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $510.00 | $412.30 | 80.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 45 | $1,800 | $387.36 | 21.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 29 | $1,189 | $254.73 | 21.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 69 | $483.00 | $235.29 | 48.7% |
| 90471 | Administration of vaccine | Office | 2023 | 17 | 17 | $595.00 | $145.04 | 24.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 89 | $356.00 | $67.83 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 401 | $61,816 | $31,417 | 50.8% |
About Dr. Albert Knouse, MD
Dr. Albert Knouse, MD is a Family Medicine healthcare provider based in Newport, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871553842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Knouse, MD has received a total of $102,367 in payments from pharmaceutical and medical device companies, with $604.82 received in 2024. These payments were reported across 821 transactions from 46 companies. The most common payment nature is "" ($92,098).
As a Medicare-enrolled provider, Knouse has provided services to 5,894 Medicare beneficiaries, totaling 16,903 services with total Medicare billing of $458,733. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Newport, PA
- Active Since 03/24/2006
- Last Updated 08/01/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871553842
Products in Payments
- Ozempic (Drug) $491.28
- TRADJENTA (Drug) $446.97
- XARELTO (Drug) $416.92
- TRELEGY ELLIPTA (Drug) $413.98
- ELIQUIS (Drug) $369.21
- FARXIGA (Drug) $340.01
- Prolia (Biological) $307.63
- JANUVIA (Drug) $294.51
- Aimovig (Biological) $269.94
- XIFAXAN (Drug) $263.65
- JARDIANCE (Drug) $245.26
- CHANTIX (Drug) $243.21
- ENTRESTO (Drug) $235.77
- VRAYLAR (Drug) $231.85
- Victoza (Drug) $203.18
- NURTEC ODT (Drug) $178.11
- TRULICITY (Drug) $177.95
- BREO (Drug) $177.22
- ANORO (Drug) $158.22
- Tresiba (Drug) $150.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newport
Dr. Clayton Kersting, M.d, M.D
Family Medicine — Payments: $35,414
Family Medicine $35,414
Catherine Spiker, D.o, D.O
Family Medicine — Payments: $22,819
Family Medicine $22,819
Rajkamal Harricharan Singh
Family Medicine — Payments: $21,552
Family Medicine $21,552
Mr. Michael Hood, Md, MD
Family Medicine — Payments: $19,457
Family Medicine $19,457
Karl Sitterly, M.d, M.D
Family Medicine — Payments: $16,066
Family Medicine $16,066
Dr. David Kickliter, Md, MD
Family Medicine — Payments: $12,702
Family Medicine $12,702